Steven Girgenti - Feb 16, 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Executive Chairman, Director
Signature
/s/ Maria Zannes, as attorney-in-fact for Steven Girgenti
Stock symbol
BIAF
Transactions as of
Feb 16, 2024
Transactions value $
$60,000
Form type
4
Date filed
3/29/2024, 04:53 PM
Previous filing
Feb 2, 2024
Next filing
Apr 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $60K +39.5K +4.15% $1.52 992K Feb 16, 2024 Direct F1
holding BIAF Common Stock 8.96K Feb 16, 2024 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, which shares will vest in full on February 16, 2027, the third anniversary of the grant date.
F2 These shares owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.